GlaucomaNCT01855802
Greek Physicians Perceptions Regarding Generics Prescribing in Glaucoma
An observational study of Glaucoma, run by Democritus University of Thrace at 1 site in Greece.
Trial summary
This attempts to investigate the perceptions of Greek Ophthalmologists regarding generics prescription in glaucoma by means of a structured questionnaire. Read more about this study
- Who is it for?
- Ages 25 to 67 years
- Conditions the study is for
- Glaucoma
- How many people
- 70 participants
- Where
- 1 siteGreece
- Study dates
- Apr 2013to Oct 2013
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 25 to 67 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Greek Medical Council Members
Who may be able to join
- Licensed Registration to Greek Ophthalmology Council
Who cannot join
- -
Trial locations and contacts
1 site in 1 country.
Greece1 site
University Hospital of Alexandroupolis
Alexandroupoli, Evros, 68100
About this study
This attempts to investigate the perceptions of Greek Ophthalmologists regarding generics prescription in glaucoma by means of a structured questionnaire.
Read the detailed description
The following dimensions will be recorded
- Overall physician's empathy regarding generics in glaucoma
- Physician's prescribing habits regarding generics in glaucoma
- Physician's perceptions regarding generics cost-effectiveness in glaucoma
- Physician's perceptions regarding adequacy of Greek regulatory authorities (generic market in glaucoma)
- Physician's perceptions regarding adequacy of European regulatory authorities (generic market in glaucoma)
- Conditions
- Glaucoma
- Keywords
- Greece, Ophthalmology, Glaucoma, Generics, Perception
- Medical subject headings
- Glaucoma
What is being measured
The primary outcome is the main question the study is designed to answer.
Generic Perception
Measured: 3 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 May 2013 (estimated)
- Study startApr 2013
- Primary completionSep 2013
- Study completionOct 2013
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for GlaucomaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Enrolment
- 70 participants (actual)
Sponsor and investigators
- Lead sponsor
- Democritus University of Thrace
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Georgios Labiris, Democritus University of Thrace
- Investigators
- Georgios Labiris, PhD, Principal investigator, Democritus University of Thrace, Medical School
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01855802
- Sponsor's protocol ID
- EIT-GG-P
- Status last verified
- Jan 2017
- First submitted
- 30 Apr 2013
- Last updated
- 18 Jan 2017
- Results posted
- No
- Data monitoring committee
- No
Publications
Labiris G, Fanariotis M, Kastanioti C, Alexias G, Protopapas A, Karampitsakos T, Niakas D. Greek Physicians' Perceptions on Generic Drugs in the Era of Austerity. Scientifica (Cairo). 2015;2015:251792. doi: 10.1155/2015/251792. Epub 2015 Sep 17.
PubMed 26457225
Study at a glance
From the registry record, last updated by the sponsor on 18 Jan 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Greek Physicians Perceptions Regarding Generics Prescribing in Glaucoma
- ClinicalTrials.gov ID
- NCT01855802
- Acronym / sponsor ID
- EIT-GG-P
- Conditions
- Glaucoma
- Keywords
- Greece, Ophthalmology, Glaucoma, Generics, Perception
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 70 participants (actual)
- Lead sponsor
- Democritus University of ThraceUniversity, hospital or other
- Study start
- Apr 2013
- Primary completion
- Sep 2013 (actual)
- Study completion
- Oct 2013 (actual)
- First posted
- 17 May 2013 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This attempts to investigate the perceptions of Greek Ophthalmologists regarding generics prescription in glaucoma by means of a structured questionnaire.
Detailed description
The following dimensions will be recorded
- Overall physician's empathy regarding generics in glaucoma
- Physician's prescribing habits regarding generics in glaucoma
- Physician's perceptions regarding generics cost-effectiveness in glaucoma
- Physician's perceptions regarding adequacy of Greek regulatory authorities (generic market in glaucoma)
- Physician's perceptions regarding adequacy of European regulatory authorities (generic market in glaucoma)
Study design
Who may qualify
- Ages
- 25 to 67 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Greek Medical Council Members
Key inclusion criteria (1 listed)
- Licensed Registration to Greek Ophthalmology Council
Key exclusion criteria (1 listed)
- -
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Generic Perception
Time frame: 3 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Jan 2017.
- Results publication: PubMed 26457225Labiris G, Fanariotis M, Kastanioti C, Alexias G, Protopapas A, Karampitsakos T, Niakas D. Greek Physicians' Perceptions on Generic Drugs in the Era of Austerity. Scientifica (Cairo). 2015;2015:251792. doi: 10.1155/2015/251792. Epub 2015 Sep 17.
Related trials for Glaucoma
Active, not recruitingObservational study
Impact of Glaucoma and Visual Field Loss on Life Space
Primary Open-angle Glaucoma
Active, not recruitingObservational study
Glaucoma, Visual Field Loss, and Their Association With Life Space in Older Adults
Primary Open Angle Glaucoma
Not yet recruitingPhase 2
VGFTe-(HD)-OD-2566: Adjunctive Aflibercept Ahmed Glaucoma Valve (AAA) Study
Glaucoma
Not yet recruitingPhase 4
Iopidine to Decrease Intraocular Pressure Rise After Injections
Macular Degeneration, Diabetic Retinopathy
Recruiting
Timing of Glaucoma Drainage Device With Boston Keratoprosthesis
Corneal Transplantation, Glaucoma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Georgios Labiris, PhD principal investigator
Democritus University of Thrace, Medical School
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Glaucoma, run by Democritus University of Thrace at 1 site in Greece.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 18 Jan 2017. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Greece. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Generic Perception (time frame: 3 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01855802, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jan 2017.